Supporters
Partners
Urinary Tract Infections
An infection in the urinary system that begins when microorganisms cling to the opening of the urethra (the canal from the bladder) and begin to multiply, a urinary tract infection is mostly due to one type of bacteria - E. coli. The infection can be prevented by drinking plenty of fluids and practicing good hygiene, especially after sexual intercourse.
| Company | Product | Phase | |
| Watson Pharmaceuticals Inc | Neomycin, Polymyxin B | M | Urinary Tract Infections |
| Amdl Inc | Balofloxacin | M | Urinary Tract Infections |
| AXM Pharma Inc | Fosfomycin calcium | M | Urinary Tract Infections |
| Watson Pharmaceuticals Inc | Nitrofurantoin monohydrate, macrocrystals | M | Urinary Tract Infections |
| Valeant Pharmaceuticals International | Phenazo | M | Urinary Tract Infections |
| AXM Pharma Inc | Pipemidic acid | M | Urinary Tract Infections |
| Depomed Inc | Proquin XR | M | Urinary Tract Infections |
| Watson Pharmaceuticals Inc | Proquin XR | M | Urinary Tract Infections |
| Allergan Inc | Prosed DS | M | Urinary Tract Infections |
| Allergan Inc | Prosed EC | M | Urinary Tract Infections |
| Watson Pharmaceuticals Inc | Trimethoprim | M | Urinary Tract Infections |
| Allergan Inc | Urolene Blue | Urinary Tract Infections | |
| Osel Inc | Lactin-V | II | Urinary Tract Infections |
| NovaBay Pharmaceuticals, Inc. | NVC422 | II | Urinary Tract Infections |
Viral Infections
The successful invasion, establishment and growth of viruses in the tissues of the host. Viral infections are hard to treat because viruses live inside the body's cells. They are "protected" from medicines, which usually move through the bloodstream. Antibiotics do not work for viral infections. There are a few antiviral medicines available. Vaccines can help prevent one from getting many viral diseases.
| Company | Product | Phase | |
| Amdl Inc | Inosine | M | Viral Infections |
| Amdl Inc | Ribavirin | M | Viral Infections |
Yellow Fever
Yellow fever is a viral disease that is transmitted to humans through the bite of infected mosquitoes. Illness ranges in severity from an influenza-like syndrome to severe hepatitis and hemorrhagic fever. Yellow fever virus (YFV) is maintained in nature by mosquito-borne transmission between nonhuman primates. Transmission by mosquitoes from one human to another occurs during epidemics of “urban yellow fever.” During silent periods it occurs in 1.4 to 2.4 per 1,000 people.
| Company | Product | Phase | |
| Novartis AG | Arilvax | PA | Yellow Fever |